This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03635567
Brief Title: Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

First Submitted : August 15, 2018
First Submitted that Met QC Criteria : August 15, 2018
First Posted : August 17, 2018

Results First Submitted : September 20, 2023
Results First Submitted that Met QC Criteria : September 20, 2023
Results First Posted : October 12, 2023

Last Update Submitted that Met QC Criteria : January 12, 2024
Last Update Posted : January 17, 2024